Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
Cancer Research|June 5, 2013
PLZF confers effector functions to donor T cells that preserve graft-versus-tumor effects while attenuating GVHDArnab Ghosh, Amanda M Holland, Yildirim Dogan, et al.Cancer Immunology Research|May 20, 2014
Bevacizumab plus ipilimumab in patients with metastatic melanomaF Stephen Hodi, Donald Lawrence, Cecilia Lezcano, et al.Blood|November 2, 2018
Nrf2 regulates CD4+ T cell-induced acute graft-versus-host disease in miceJennifer J Tsai, Enrico Velardi, Yusuke Shono, et al.The Journal of Clinical Investigation|May 17, 2013
Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activityArnab Ghosh, Yildirim Dogan, Maxim Moroz, et al.Cell|September 18, 2012
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanomaChristine Guo Lian, Yufei Xu, Craig Ceol, et al.Human Pathology|March 14, 2026
The Impact of Next Generation Sequencing Studies on the Diagnosis of BAP1 Inactivated Melanocytic TumorsJonathan Braat, Nithya Sai Trichy, Lindsay Jeanne Holic, et al.The American Journal of Surgical Pathology|April 9, 2024
The Impact of Next-generation Sequencing on Interobserver Agreement and Diagnostic Accuracy of Desmoplastic Melanocytic NeoplasmsAlice Chen, Natasha Sharma, Pragi Patel, et al.Journal of Cutaneous Pathology|December 23, 2025
The Impact of Next-Generation Sequencing on Interobserver Agreement and Diagnostic Accuracy of Deep Penetrating Melanocytic NeoplasmsJulia Edwin Jeyakumar, Afua Konadu Addo, Haya Mary Beydoun, et al.Pigment Cell & Melanoma Research|July 25, 2022
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL studyLi Luo, Ronglai Shen, Arshi Arora, et al.Nature|March 31, 2022
Anatomic position determines oncogenic specificity in melanomaJoshua M Weiss, Miranda V Hunter, Nelly M Cruz, et al.Pageof 7